AVENUE THERAPEUTICS Earnings Preview: Recent $ATXI Insider Trading, Hedge Fund Activity, and More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 15 2025
0mins
Source: NASDAQ.COM
Earnings Release: AVENUE THERAPEUTICS is set to announce its quarterly earnings on March 17th, with analysts predicting $0 in revenue and a loss of -$0.58 per share.
Insider Trading Activity: In the past six months, insiders have made four trades of $ATXI stock, with an equal number of purchases and sales, while institutional investors have shown mixed activity by adding and reducing their holdings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
